Pfizer is facing material patent expirations over the next two years, but that will be over by 2030.

Pfizer Inc PFE shares are trading higher Wednesday, moving in sympathy with mRNA cancer vaccine-related companies after Merck & Co Inc MRK and Moderna Inc MRNA announced that their combination therapy ...

Pfizer agreed to a $44 million Chantix settlement. Here's who may qualify, how to file a claim and the deadline to submit.

A biomanufacturing facility in Everett that Pfizer decided to shut down before it opened is getting a new lease on life, with ...

Shares of global pharmaceutical company Pfizer (NYSE:PFE) jumped 3.8% in the afternoon session after positive clinical trial ...

Pfizer's dividend yield is 7% for a very good reason: investors are worried about the risk of a dividend cut.

So far, Pfizer has been an also-ran in the GLP-1 race, but that could change if its long-acting weight-loss medication takes off.

Pfizer's $31 billion bond sale ranks among the largest ever, but it's still only half the size, adjusted for inflation, of ...

Pfizer, Chevron, and AbbVie have already rewarded dividend investors with strong 2026 gains, but the bull case for 2027 ...

The pharmaceutical giant reached new heights during the pandemic while becoming a prominent voice for the scientific ...

The submission is supported by efficacy and safety data from the Phase III VALOR clinical trial.